胎儿透明隔腔及韦尔加腔增大:是否需要关注
回顾性分析本机构产前超声发现的15例透明隔腔或韦尔加腔增大胎儿,平均孕22.7±5.9周,13例合并先天畸形,10例主要不良结局(5例严重),4例疑似21三体(3例确诊、1例可能)。作者认为增大应提示遗传咨询,可考虑无创产前检测(游离DNA)、羊膜腔穿刺微阵列或两者。
要点
- 胎儿透明隔腔或韦尔加腔增大时,13/15例合并先天畸形,10例主要不良结局(5例严重)。
- 4例疑似21三体(3例确诊、1例可能),另有2例遗传病。
- 产前超声孤立性透明隔腔增大5例中,1例新生儿无脑回,3例早产(1例死亡、1例临终关怀、1例正常)。
核心结论
- 本队列合并临床异常较多:3例确诊21三体、1例可能21三体、2例遗传病、10例主要不良结局(5例严重);作者认为透明隔腔或韦尔加腔增大值得考虑遗传咨询,可包括无创产前检测(游离DNA)、羊膜腔穿刺微阵列或两者。
研究设计与样本
- 回顾性研究,纳入本机构产前超声发现透明隔腔或韦尔加腔增大的高危和低危患者15例,收集超声指征、诊断孕周、合并畸形及随访结局(进一步影像、核型、脑异常诊断、先天畸形)。
关键影像表现/征象
- 9例为透明隔腔增大,6例为韦尔加腔增大。
- 平均孕周22.7±5.9周,11例分娩。
- 产前超声孤立性透明隔腔增大5例:1例新生儿无脑回,3例早产(1例死亡、1例临终关怀、1例正常),1例失访。
诊断标准与关键数值
- 产前超声诊断透明隔腔或韦尔加腔增大;15例中13例合并先天畸形,10例主要不良结局(5例严重),4例正常或轻微异常,1例失访。
临床应用与阅片要点
- 作者认为透明隔腔或韦尔加腔增大值得考虑遗传咨询,可包括无创产前检测(游离DNA)、羊膜腔穿刺微阵列或两者(原文为作者建议)。
局限性
- 原文自述研究队列小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate fetal cases identified at our institution to determine whether an enlarged cavum septi pellucidi or cavum vergae is associated with other fetal abnormalities and whether its presence warrants more detailed investigation of the fetus.
METHODS: In a retrospective study, 15 high- and low-risk patients undergoing prenatal sonography who had an enlarged cavum septi pellucidi or cavum vergae identified were reviewed. Data were collected for the sonographic study indication, gestation age at diagnosis of a prominent cavum, and associated anomalies. Follow-up outcome data regarding further imaging, karyotype, diagnosis of brain anomaly, and associated congenital abnormalities were obtained.
RESULTS: Fifteen patients met the inclusion criteria. Nine patients were identified as having a prominent cavum septi pellucidi, and 6 were identified as having a prominent cavum vergae. The mean gestational age ± SD was 22.7 ± 5.9 weeks. Eleven patients made it to delivery. Of the 15 patients, 4 were thought to have trisomy 21, and 13 had congenital anomalies. Outcomes included 10 major adverse outcomes, 4 cases with normal development or minor abnormalities, and 1 lost to follow-up. An isolated dilated cavum on prenatal sonography was seen in 5 cases: 1 with lissencephaly on a neonatal examination, 3 premature deliveries (1 demise, 1 hospice, and 1 normal), and 1 unknown.
CONCLUSIONS: Our cohort had many associated clinical anomalies: 3 confirmed trisomy 21 and 1 probable trisomy 21, 2 genetic disorders, and 10 major adverse outcomes, 5 of which were grave. Although we studied a small cohort, we conclude that an enlarged cavum septi pellucidi or cavum vergae warrants consideration of genetic counseling, which may include noninvasive prenatal testing (cell-free DNA), amniocentesis with microarray testing, or both.
引用
- Ho YK, Turley M, Marc-Aurele KL, et al. Enlarged Cavum Septi Pellucidi and Vergae in the Fetus: A Cause for Concern. J Ultrasound Med. 2017. PMID: 28417514. doi:10.7863/ultra.16.06081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。